Therapeutic Equivalence of Budesonide/Formoterol Delivered via Breath-Actuated Inhaler vs pMDI

Respiratory Medicine - United Kingdom
doi 10.1016/j.rmed.2014.12.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Device-Handling Study of a Novel Breath-Actuated Inhaler, Synchrobreathe®, Versus a pMDI

Respiratory Medicine
PulmonaryRespiratory Medicine
2020English

Using a Combination Inhaler (Budesonide Plus Formoterol) as Rescue Therapy Improves Asthma Control

BMJ
2007English

Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaAs Needed Budesonide-Formoterol Versus Maintenance Budesonide in Mild Asthma

Pediatrics
Child HealthPediatricsPerinatology
2018English

Poor Adherence With Inhaled Corticosteroids for Asthma: Can Using a Single Inhaler Containing Budesonide and Formoterol Help?

British Journal of General Practice
MedicineFamily Practice
2008English

Bone and Ocular Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in COPD: A 52-Week Randomized Study

Respiratory Research
PulmonaryRespiratory Medicine
2019English

Budesonide-Formoterol Reliever Therapy in Asthma

Thorax
PulmonaryRespiratory Medicine
2006English

Combination Formoterol and Budesonide as Maintenance and Reliever Therapy Versus Combination Inhaler Maintenance for Chronic Asthma in Adults and Children

Cochrane Database of Systematic Reviews
2013English

Budesonide/Formoterol Combination in COPD: A US Perspective

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2010English

Tolerability of Budesonide/Formoterol in Patients of Kazakhstan Rural Regions

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy